All Type of News
Doctors and pharmas tense over stricter regulations for rebates relate to international symposiums
The industry has paid attention to the meetup among authorities to eradicate illegal rebates.
With the government’s will towards the anti-corruptive policy, the Anti-Corruption and Civil Rights Commission(ACRC) sugge...
Intensified generic-based management in Korean pharmaceutical industry
Korean pharmaceutical companies were criticized to still manage their business relying on generic drugs. 3 of 4 medicines approved this year were ETC, and most ETC drugs were reportedly generics Korean pharmaceutical ...
Insurance Benefit Evaluation Committee accepts propriety of health insurance benefits for ‘Iclusig Tab’
The Health Insurance Benefit Evaluation Committee accepted propriety of Iclusig. Tecentriq Inj will also receive a conditional uninsured evaluation.
The Health Insurance Review & Assessment Service(HIRA) Health Insur...
Public pharmaceutical companies with largest merchandise sales
Both KOSPI and KOSDAQ pharmaceutical companies had a significant increase of collective merchandise sales by this 3rd quarter year-on-year. When it comes to merchandise sales/total sales ratio, KOSPI pharmaceutical co...
Will government create independent act for biologics from Pharmaceutical Affairs Law?
The ‘High-Tech Biologic Act’ will be enacted to control biologics, such as cell therapies and gene therapies and manage their development, approval and technology support based on their characteristics.
The Ministry ...
Hanmi Pharm, Celltrion and Samsung Biologics in order for brand reputation
According to the Listed Pharmaceutical Company Brand Reputation Research for December 2017, it was analyzed Hanmi Pharm, Celltrion and Samsung Biologics were on the 1st, 2nd and 3rd respectively.
The Korea Reputation...
‘Hot potato’ over changes in the list of emergency household medicines before 5th deliberative committee
Will new products be included in the list of emergency household medicines? Or won’t there be no major change?
While the 5th meeting will be the final one to adjust the products, the pharmaceutical association has cr...
Series of medicines running out of stock or suspended manufacturing due to problems in ingredient supply
With the unstable ingredient supply and manufacturing delays, there have been an endless number of medicines running temporary out-of-stock or suspended manufacturing.
According to the industry concerned, Sanofi-Aven...
Which pharmaceutical companies spent the most in R&D?
KOSPI pharmaceutical companies increased collective R&D expenses by this 3rd quarter year-on-year, but KOSDAQ pharmaceutical companies had a decrease. When it comes to the collective 3rd quarter’s R&D expense/sales ra...
Non-small cell lung cancer treatment ‘Tagrisso’ applied for health insurance benefits from 5 December
The health insurance benefits of ‘Tagrisso,’ a non-small cell lung cancer treatment completed with the drug price negotiation, was decided registration and will be applied from 5 December.
Compensation plans for the ...
